FG
PROF

Formula Growth’s Profound Medical PROF Stock Holding History

Formula Growth’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
241,138
+38,220
+19% +$264K 0.71% 52
2025
Q4 		$1.6M Hold
202,918
– – 0.62% 63
2025
Q3 		$992K Sell
202,918
-38,000
-16% -$194K 0.35% 93
2025
Q2 		$1.42M Sell
240,918
-5,107
-2% -$27K 0.54% 77
2025
Q1 		$1.43M Sell
246,025
-3,975
-2% -$27.4K 0.58% 67
2024
Q4 		$1.88M Buy
+250,000
New +$1.92M 0.64% 64

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Formula Growth's PROF Position: Q1 2026 in Review

Formula Growth increased its Profound Medical (PROF) stake by 19% in Q1 2026, buying an estimated $264K and bringing the position to 241,138 shares worth $1.56M. The position accounts for 0.71% of the portfolio, ranked #52.

Formula Growth first reported a position in PROF in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.88M in Q4 2024. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Formula Growth held 241,138 shares of Profound Medical worth $1.56M as of Q1 2026.
  • Formula Growth bought 38,220 Profound Medical shares in Q1 2026, an estimated $264K.
  • Profound Medical made up 0.71% of Formula Growth's portfolio in Q1 2026, its #52 holding.
  • Formula Growth first reported a position in Profound Medical in Q4 2024 and has held it in 6 quarters since.
  • Formula Growth's Profound Medical position peaked at $1.88M in Q4 2024.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.